I agree that this site is using cookies. You can find further informations here.
X
Kutoh, Eiji
26  results:
Search for persons X
?
1

Diverse Strategies for Modulating Insulin Resistance: Causa..:

Kutoh, Eiji ; Kuto, Alexandra N. ; Okada, Rumiko..
Medicina.  60 (2024)  6 - p. 991 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Alogliptin: a DPP-4 inhibitor modulating adipose tissue ins..:

Kutoh, Eiji ; Kuto, Alexandra N. ; Akiyama, Midori..
European Journal of Clinical Pharmacology.  79 (2023)  7 - p. 947-959 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Complementary effects on glycaemic and non‐glycaemic parame..:

Kutoh, Eiji ; Kuto, Alexandra N. ; Wada, Askuka..
International Journal of Clinical Practice.  75 (2021)  12 - p. , 2021
Link: https://doi.org/10.1111/..
 
?
4

Regulation of serum uric acid with canagliflozin monotherap..:

Kutoh, Eiji ; Wada, Asuka ; Kuto, Alexandra N..
Int. Journal of Clinical Pharmacology and Therapeutics.  57 (2019)  12 - p. 590-595 , 2019
Link: https://doi.org/10.5414/..
 
?
5

Efficacy and safety of dulaglutide in patients with absolut..:

Kutoh, Eiji ; Hayashi, Jyunka ; Kuto, Alexandra N.
Endocrine Regulations.  53 (2019)  3 - p. 187-190 , 2019
Link: https://doi.org/10.2478/..
 
?
6

Two Glucose-Lowering Mechanisms of Canagliflozin Depending ..:

Kutoh, Eiji ; Wada, Asuka ; Murayama, Teruma.
Drugs in R&D.  18 (2018)  4 - p. 309-315 , 2018
Link: https://doi.org/10.1007/..
 
?
7

Canagliflozin as an Initial Therapy in Drug-Naïve Subjects ..:

Kutoh, Eiji ; Wada, Asuka ; Murayama, Teruma.
Drugs in R&D.  17 (2017)  2 - p. 313-320 , 2017
Link: https://doi.org/10.1007/..
 
?
8

Teneligliptin, a Chemotype Prolyl-Thiazolidine-Based Novel ..:

Kutoh, Eiji ; Wada, Asuka ; Terayama, Sayaka
Clinical Drug Investigation.  36 (2016)  10 - p. 809-818 , 2016
Link: https://doi.org/10.1007/..
 
?
9

Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depen..:

Kutoh, Eiji ; Murayama, Teruma ; Wada, Asuka.
Drugs in R&D.  16 (2016)  4 - p. 369-376 , 2016
Link: https://doi.org/10.1007/..
 
?
10

Alogliptin as an initial therapy in patients with newly dia..:

Kutoh, Eiji ; Ukai, Yasuhiro
Endocrine.  41 (2012)  3 - p. 435-441 , 2012
Link: https://doi.org/10.1007/..
 
?
11

Sitagliptin is effective and safe as add-on to insulin in p..:

Kutoh, Eiji
Journal of Medical Case Reports.  5 (2011)  1 - p. , 2011
Link: https://doi.org/10.1186/..
 
?
12

Insulin-dependent actions of pioglitazone in newly diagnose..:

Kutoh, Eiji ; Fukushima, Takuya
Endocrine.  35 (2009)  3 - p. 333-340 , 2009
Link: https://doi.org/10.1007/..
 
?
13

Transactivation of the IGFBP-2 promoter in human tumor cell..:

Elminger, Martin W. ; Bell, Mathias ; Schüett, Burkhardt S....
Molecular and Cellular Endocrinology.  175 (2001)  1-2 - p. 211-218 , 2001
Link: https://doi.org/10.1016/..
 
?
14

Identification and characterization of the putative retinob..:

Kutoh, Eiji ; Margot, Jean B. ; Schwander, Jürg
Cancer Letters.  136 (1999)  2 - p. 187-194 , 1999
Link: https://doi.org/10.1016/..
 
?
15

QUANTIFICATION OF THE FULL LENGTH LEPTIN RECEPTOR (OB-Rb) I..:

Kutoh, Eiji ; Boss, Olivier ; Levasseur, Frédéric.
Life Sciences.  62 (1997)  5 - p. 445-451 , 1997
Link: https://doi.org/10.1016/..
 
1-15